Table 2.

Association of patients’ clinical parameters with the mean log10 TTV levels over the 12-month study period (CNI, calcineurin inhibitors; GFR, glomerular filtration rate; mTORi, mammalian target of rapamycin inhibitors, m², square meters)

Mean log10 TTV during the 12-month study period
Baseline parameters	p value
Gender	0.420
Primary disease	0.917
Age at transplantation	0.069
Type of donation	0.722
Number of mismatches	0.145
Follow-up parameters
Age at study begin	0.695
Post-transplantation time	0.041*
Presence of donor-specific antibodies (DSA)	0.517
Immunosuppressive therapy
Triple or dual immunosuppression (with or without anti prolif. medication)	0.076
Type of immunosuppression (CNI or mTORi-based)	0.023*

*p < 0.05